Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients

In 2022, the antigenically divergent SARS-CoV-2 omicron variants (BA.1, BA.2, BA.4, BA.5) outcompeted previous variants and continued to cause substantial numbers of illnesses and deaths. We evaluated the safety and immunogenicity of the bivalent original/omicron BA.4/BA.5 Pfizer/BioNTech vaccine ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Peled, Yael, Afek, Arnon, Patel, Jignesh K., Raanani, Ehud, Segev, Amit, Ram, Eilon, Fardman, Alexander, Beigel, Roy, Atari, Nofar, Kliker, Limor, Elkader, Bayan Abd, Mandelboim, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Heart and Lung Transplantation. 2023
Materias:
ISHT Meeting
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112987/
https://www.ncbi.nlm.nih.gov/pubmed/37084801
http://dx.doi.org/10.1016/j.healun.2023.03.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112987/
https://www.ncbi.nlm.nih.gov/pubmed/37084801
http://dx.doi.org/10.1016/j.healun.2023.03.016

Ejemplares similares